Skip to main content
Figure 1 | Journal for ImmunoTherapy of Cancer

Figure 1

From: Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells

Figure 1

CSPG4 expression in tumor cell lines from multiple histologies by FACS. Fluorescence-activated cell sorting analysis (FACS) was performed using a conjugated mAb (anti-hNG2/MCSP) specific for human chondroitin sulfate proteoglycan 4 (CSPG4) according to manufacturers’ recommendations (R&D Systems, Minneapolis, MD). Representative isotype controls are shown in the top left hand panels. Cell lines and percent expression were as identified.

Back to article page